Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2023-12-27 00:00:00 ET · period of report 2023-12-22 · accession 0001214659-23-016923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-27 | 2023-12-26 | ALZN | AULT MILTON C III | 10% | P - Purchase | $0.9 | +500 | 26.0K | +2% | +$450 |
| 2023-12-27 | 2023-12-22 | ALZN | AULT MILTON C III | 10% | P - Purchase | $0.92 | +200 | 166.9K | +0.1% | +$184 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-26 | P | A | 500 | $0.9 | 26,032 | I | — | — | |
| 2 | Common | Common Stock | 2023-12-22 | P | A | 200 | $0.92 | 166,866 | D By Ault Alpha LP | — | — | (F1) Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP. |